NCT06044233View on ClinicalTrials.gov

A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 28, 2023

Primary Completion Date

October 23, 2023

Study Completion Date

November 8, 2023

Conditions
COVID-19
Interventions
DRUG

STI-1558

STI-1558 test preparation and reference preparation

Trial Locations (1)

Unknown

Zhejiang Xiaoshan Hospital, Hangzhou

All Listed Sponsors
lead

Zhejiang ACEA Pharmaceutical Co. Ltd.

INDUSTRY

NCT06044233 - A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter